Iovance Biotherapeutics and Adaptimmune brought first-of-their-kind cell therapy cancer treatments to market. Others had to ...
If you invested $10,000 in Australia's best-performing stock a year ago would have turned that into a $46,400 bonanza. Here's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback